1. Vaccine BNT162b2—Conditions of Authorisation Under Regulation 174 (Medicines and Healthcare Products Regulatory Agency, 2020); https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine
2. Regulatory Approval of COVID-19 Vaccine AstraZeneca (Medicines and Healthcare Products Regulatory Agency, 2020); https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca
3. Regulatory Approval of COVID-19 Vaccine Moderna (Medicines and Healthcare Products Regulatory Agency, 2021); https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna
4. Joint Committee on Vaccination and Immunisation: Advice on Priority Groups for COVID-19 Vaccination, 30 December 2020 (Joint Committee on Vaccination and Immunisation, 2020); https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020
5. Vaccinations in United Kingdom (Public Health England, 2021); https://coronavirus.data.gov.uk/details/vaccinations